US FDA allows marketing of new device to help treat carbon monoxide poisoning



The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning. The device uses a novel method for quickly removing carbon monoxide from the body by increasing a patient’s rate of breathing.

CONTINUE READING ON www.fda.gov

                   

Related News

Loading...